Recent Finacing
Recent Raise
Elevation Pharmaceuticals, based in San Diego, develops inhaled aerosol therapies; lead candidate EP-101 (glycopyrrolate) for moderate-to-severe COPD delivered via an optimized eFlow nebulizer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors